Discontinuing anticoagulation following successful atrial fibrillation ablation in patients with prior strokes

Journal of Interventional Cardiac Electrophysiology

Volumn 38, Issue 3, 2013, Pages 147-153

  Winkle, Roger A ^a,b   Mead, R Hardwin ^a,b   Engel, Gregory ^a,b   Kong, Melissa H ^a,b   Patrawala, Rob A ^a,b  

^a Silicon Valley Cardiology   (United States)

^b SEQUOIA HOSPITAL   (United States)

Author keywords

Ablation; Anticoagulation after AF ablation; Atrial fibrillation; Atrial fibrillation ablation

Indexed keywords

ACETYLSALICYLIC ACID; ALACHLOR; AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; DABIGATRAN; ENOXAPARIN; HEPARIN; RIVAROXABAN; WARFARIN;

AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CARDIOVASCULAR CATHETER; CATHETER ABLATION; CEREBROVASCULAR ACCIDENT; CHADS2 SCORE; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; MECHANICAL HEART VALVE; NEEDLE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECURRENT DISEASE; TRANSIENT ISCHEMIC ATTACK; TREATMENT WITHDRAWAL;

ADMINISTRATION, ORAL; AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; CATHETER ABLATION; COMORBIDITY; DISEASE-FREE SURVIVAL; FEASIBILITY STUDIES; FEMALE; HUMANS; INCIDENCE; ISCHEMIC ATTACK, TRANSIENT; LONGITUDINAL STUDIES; MALE; RISK FACTORS; STROKE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84889017342     PISSN: 1383875X     EISSN: 15728595     Source Type: Journal    
DOI: 10.1007/s10840-013-9835-1     Document Type: Article

References (21)

1. Calkins, H., Kuck, K. H., Cappato, R., Brugada, J., Camm, A. J., Chen, S., et al. (2012). 1012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Journal of Interventional Cardiac Electrophysiology, 33, 171-257.
2. Camm, A. J., Kirchhof, P., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., et al. (2010). Guidelines for the management of atrial fibrillation. European Heart Journal, 31, 2369-2429.
3. Verma, A., Macle, L., Cox, J., & Skanes, A. C. (2011). Canadian Cardiovascular Society atrial fibrillation guidelines 2010: catheter ablation for atrial fibrillation/atrial flutter. Canadian Journal of Cardiology, 27, 60-66.
4. Bunch, T. J., May, H. T., Blair, T. L., Weiss, J. P., Crandall, B. G., Osborn, J. S., et al. (2013). Atrial fibrillation patients have long-term stroke rates similar to patients without atrial fib regardless of CHADS2 score. Heart Rhythm., 10, 1272-1277.
5. Oral, H., Chugh, A., Özaydin, M., Good, E., Fortino, J., Sankaran, S., et al. (2006). Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation. Circulation, 114, 759-765.
6. Themistoclakis, S., Corrado, A., Marchlinski, F. E., Jais, P., Zado, E., Rossillo, A., et al. (2010). The risk of thromboembolism and need for oral anticoagulation after successful atrial fibrillation ablation. Journal of the American College of Cardiology, 55, 735-743.
7. Winkle, R. A., Mead, R. H., Engel, G., & Patrawala, R. A. (2012). Trends in atrial fibrillation ablation: have we maximized the current paradigms? Journal of Interventional Cardiac Electrophysiology, 34, 115-123.
8. Winkle, R. A., Mead, R. H., Engel, G., & Patrawala, R. A. (2011). Safety of lower activated clotting times during atrial fibrillation ablation using open irrigated tip catheters and a single transseptal puncture. The American Journal of Cardiology, 107, 704-708.
9. Winkle, R. A., Mead, R. H., Engel, G., & Patrawala, R. A. (2011). The use of a radiofrequency needle improves the safety and efficacy of transseptal puncture for atrial fibrillation ablation. Heart Rhythm, 8, 1411-1415.
10. Winkle, R. A., Mead, R. H., Engel, G., & Patrawala, R. A. (2011). Atrial fibrillation ablation: perpetual motion of open irrigated tip catheters at 50 watts is safe and improves outcomes. Pacing and Clinical Electrophysiology, 34, 531-539.
11. Winkle, R. A., Mead, R. H., Engel, G., Kong, M. H., & Patrawala, R. A. (2012). The use of dabigitran immediately following atrial fibrillation ablation. Journal of Cardiovascular Electrophysiology, 23, 264-268.
12. 2 score ≤3. A long-term outcome study. Circulation. Arrhythmia and Electrophysiology, 4, 615-621.
13. 2-VASc scores in the prediction of clinical outcomes in patients with atrial fibrillation after catheter ablation. Journal of the American College of Cardiology, 58, 2380-2385.
14. Winkle, R. A., Mead, R. H., Engel, G., Kong, M. H., & Patrawala, R. A. (2012). Atrial arrhythmia burden on long-term monitoring in asymptomatic patients late after atrial fibrillation ablation. The American Journal of Cardiology, 110, 840-844.
15. Steven, D., Rostock, T., Lutomsky, B., Klemm, H., Servatius, H., Drewitz, I., et al. (2008). What is the real atrial fibrillation burden after catheter ablation of atrial fibrillation? A prospective rhythm analysis in pacemaker patients with continuous atrial monitoring. European Heart Journal, 29, 1037-1042.
16. Oral, H., Veerareddy, S., Good, E., Hall, B., Cheung, P., Tamirisa, K., et al. (2004). Prevalence of asymptomatic recurrences of atrial fibrillation after successful radiofrequency catheter ablation. Journal of Cardiovascular Electrophysiology, 15, 920-924.
17. Klemm, H. U., Ventura, R., Rostock, T., Brandstrup, B., Risius, T., Meinertz, T., et al. (2006). Correlation of symptoms to ECG diagnosis following atrial fibrillation ablation. Journal of Cardiovascular Electrophysiology, 17, 146-150.
18. Verma, A., Minor, S., Kilicaslan, F., Patel, D., Hao, S., Beheiry, S., et al. (2007). Incidence of atrial arrhythmias detected by permanent pacemakers (PPM) post-pulmonary vein antrum isolation (PVAI) for atrial fibrillation (AF): correlation with symptomatic recurrence. Journal of Cardiovascular Electrophysiology, 18, 601-606.
19. Hindricks, G., Piorkowski, C., Tanner, H., Kobza, R., Gerds-Li, J., Carbucicchio, C., et al. (2005). Perception of atrial fibrillation before and after radiofrequency catheter ablation. Circulation, 112, 307-313.
20. Glotzer, T. V., Daoud, E. G., Wyse, G., Singer, D. E., Ezekowitz, M. D., Hilker, C., et al. (2009). The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study. Circulation Arrhythmia and Electrophysiology, 2, 474-480.
21. Chao, T. F., Cheng, C. C., Lin, W. S., Tsao, H. M., Lin, Y. J., Chang, S. L., et al. (2011). Associations among the CHADS(2) score, atrial substrate properties and outcome of catheter ablation in patients with paroxysmal atrial fibrillation. Heart Rhythm, 8, 1155-1159.